| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 2.98 mm | 2.98 mm | 2.98 mm | 2.98 mm | 2.98 mm | 2.98 mm |
| Cash burn (monthly) | 1.01 mm | 246.83 k | 725.67 k | 1.32 mm | 1.02 mm | 878.67 k |
| Cash used (since last report) | 5.13 mm | 1.26 mm | 3.70 mm | 6.75 mm | 5.21 mm | 4.48 mm |
| Cash remaining | -2.15 mm | 1.72 mm | -717.91 k | -3.77 mm | -2.23 mm | -1.50 mm |
| Runway (months of cash) | -2.1 | 7.0 | -1.0 | -2.8 | -2.2 | -1.7 |
| 13F holders | Current |
|---|---|
| Total holders | 19 |
| Opened positions | 1 |
| Closed positions | 4 |
| Increased positions | 3 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 191.12 mm |
| Total shares | 4.33 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Acorn Bioventures | 2.82 mm | $0.00 |
| Dellora Investments | 648.75 k | $0.00 |
| CVI Investments | 280.98 k | $2.19 mm |
| Aspire Capital Fund | 270.00 k | $2.28 mm |
| Armistice Capital | 145.00 k | $143.55 mm |
| Eastern Capital | 108.36 k | $436.00 k |
| Point72 Asset Management | 15.33 k | $15.18 mm |
| Acadian Asset Management | 14.29 k | $14.00 k |
| UBS UBS | 12.55 k | $12.43 mm |
| Geode Capital Management | 10.60 k | $10.49 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 Feb 25 | Avraham Ben-Tzvi | NQSO Common Stock | Grant | Acquire A | No | No | 0.33 | 700,000 | 231.00 k | 700,000 |
| 26 Feb 25 | Lazar David E. | Common Stock | Sell | Dispose S | No | No | 0.0283 | 194,628,820 | 5.51 mm | 0 |
| 26 Feb 25 | Lazar David E. | Common Stock | Option exercise | Acquire M | No | No | 0 | 191,978,820 | 0.00 | 194,628,820 |
| 26 Feb 25 | Lazar David E. | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,650,000 | 0.00 | 2,650,000 |
| 26 Feb 25 | Lazar David E. | Series D Convertible Preferred Stock Common Stock | Option exercise | Dispose M | No | No | 0 | 1,745,262 | 0.00 | 354,738 |
| 26 Feb 25 | Lazar David E. | Series C Convertible Preferred Stock Common Stock | Option exercise | Dispose M | No | No | 0 | 1,000,000 | 0.00 | 0 |
